P
TARA
Protara Therapeutics Inc
4.960
-0.350-6.59%After Hours: 5.05 +0.09 +1.75%17:37 04/10 EDT
OPEN/PREV CLOSE5.23/5.31
TODAY RANGE4.920-5.24
VOL686.82K
MARKET CAP268.26M
52 WEEK RANGE2.770-7.82
AVG VOL (3M)1.08M
% TURNOVER1.27%
TURNOVER--
P/E (TTM)-3.6990
% RANGE6.03%
EPS(TTM)-1.3409
P/E(FORWARD)-3.2104
P/B1.353
BVPS3.665
DIVIDEND--
P/S0.1857
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP262.17M
SHARES OUTSTANDING54.08M
NEXT EARNINGS05/06-05/11
FREE FLOAT52.86M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
JonesTrading Remains a Buy on Protara Therapeutics (TARA)
TipRanks·03/30 13:19
Protara Therapeutics Highlights Positive TARA-002 Phase 2 Results
Reuters·03/30 12:06
Protara warrants set to expire June 29 after trial endpoint met
TipRanks·03/12 11:28
J.P. Morgan Sticks to Its Buy Rating for Protara Therapeutics (TARA)
TipRanks·03/11 13:29
Protara Therapeutics (TARA) Receives a Buy from Oppenheimer
Seeking Alpha·03/10 19:11
Protara Therapeutics GAAP EPS of -$0.37
TipRanks·03/10 12:11
Protara Therapeutics reports Q4 EPS (37c), consensus (31c)
TipRanks·03/10 12:11
Protara Therapeutics sees cash runway into 2028
Reuters·03/10 12:07
Protara Q4 net loss widens on higher R&D spend
Dow Jones·03/10 12:01
*Protara Therapeutics 4Q Loss $17.3M >TARA